J&J | JNJ - Debt


J&J reported $47.93B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
AbbVie USD 67.5B 67.5B Dec/2025
Abbott USD 13.86B 919M Dec/2025
Amgen USD 54.6B 17M Dec/2025
AstraZeneca USD 33.92B 4.3B Mar/2026
Baxter International USD 9.78B 68M Dec/2025
Bayer EUR 36.45B 2.93B Dec/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Biogen USD 6.56B 275.1M Mar/2026
Boston Scientific USD 11.44B 610M Dec/2025
Bristol-Myers Squibb USD 47.14B 3.9B Dec/2025
CONMED USD 834.94M 18.81M Dec/2025
Cooper Companies USD 2.5B 5.6M Dec/2025
Dexcom USD 1.24B 900K Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Eli Lilly USD 42.5B 3.6M Dec/2025
Gilead Sciences USD 24.94B 5M Dec/2025
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
Globus Medical USD 118.66M 687K Dec/2025
Insulet USD 949.2M 65.6M Dec/2025
Integra LifeSciences USD 2.04B 6.27M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 47.93B 2.14B Dec/2025
Medtronic USD 28.07B 1.03B Dec/2025
Merck USD 49.34B 7.97B Dec/2025
Merit Medical Systems USD 821.57M 420K Dec/2025
Novartis USD 47B 11.62B Mar/2026
Pfizer USD 63.73B 231M Mar/2026
Regeneron Pharmaceuticals USD 2.71B 300K Mar/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 20.33B 1.43B Dec/2025
Stryker USD 14.22B 635M Mar/2026
Tandem Diabetes Care USD 444.48M 4.81M Dec/2025
Teva Pharmaceutical Industries USD 17.09B 21M Dec/2025
Vertex Pharmaceuticals USD 1.99B 44M Mar/2026
Zimmer Biomet Holdings USD 7.47B 48.1M Mar/2026
Zoetis USD 9.24B 1.96B Dec/2025